Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Benjamín L. Sievers, Saborni Chakraborty, Yong Xue, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 634
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 471
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 340-348
Open Access | Times Cited: 171
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
Simone I. Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 880-886.e4
Open Access | Times Cited: 105
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance
Ala M. Shaqra, Sarah N. Zvornicanin, Qiu Yu J. Huang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 93
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
Caroline Atyeo, Lydia L. Shook, Sara Brigida, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 75
Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey
Raffaele Izzo, Valentina Trimarco, Pasquale Mone, et al.
Pharmacological Research (2022) Vol. 183, pp. 106360-106360
Open Access | Times Cited: 71
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 67
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
Fei Gao, Vamsee Mallajosyula, Prabhu S. Arunachalam, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 864-878.e4
Open Access | Times Cited: 58
Durability of immune responses to mRNA booster vaccination against COVID-19
Prabhu S. Arunachalam, Lilin Lai, Hady Samaha, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 54
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
Valeria Fumagalli, Micol Ravà, Davide Marotta, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 633-643
Open Access | Times Cited: 24
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
Ranjan K. Mohapatra, Satwik Kuppili, Tarun Kumar Suvvari, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 769-788
Open Access | Times Cited: 58
Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective
Ranjan K. Mohapatra, Venkataramana Kandi, Sarika Verma, et al.
ChemBioChem (2022) Vol. 23, Iss. 9
Open Access | Times Cited: 51
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine
Prabhu S. Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 658
Open Access | Times Cited: 50
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy
Mary Prahl, Yarden Golan, Arianna G. Cassidy, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy
Deepak Kumar, Sonam Verma, Indira U. Mysorekar
Translational research (2022) Vol. 251, pp. 84-95
Open Access | Times Cited: 46
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases
Roya Monica Dayam, Jaclyn C. Law, Rogier Goetgebuer, et al.
JCI Insight (2022) Vol. 7, Iss. 11
Open Access | Times Cited: 44
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 289-306
Open Access | Times Cited: 42
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
I‐Jung Lee, Cheng‐Pu Sun, Ping‐Yi Wu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 40
SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis
Marisa E. McGrath, Yong Xue, Carly Dillen, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 37
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top